Form 4: Merck Director Kathy J. Warden Reports Changes in Personal Stock Holdings and Phantom Stock Acquisition

Merck & Co., Inc. Director Kathy J. Warden reported the disposition of 500 shares of common stock and the acquisition of 2,863.0921 phantom stock units valued at $76.84 per unit.

Summary

• Kathy J. Warden, a Director of Merck & Co., Inc. (MRK), filed a Form 4 with the SEC.
• On May 30, 2025, Ms. Warden disposed of 500 shares of Merck Common Stock.
• On the same date, Ms. Warden acquired 2,863.0921 phantom stock units.
• These phantom stock units were valued at $76.84 per unit at the time of acquisition.
• The phantom stock units are designed to be settled 100% in cash upon Ms. Warden's termination of service, in accordance with a distribution schedule elected under the Plan for Deferred Payment of Directors' Compensation.
• Following these transactions, Ms. Warden's direct beneficial ownership of phantom stock units increased to 15,503.599 units, which includes units acquired through dividend reinvestment transactions.

Sentiment

Score: 5

Explanation: The document reports a director's disposition of a small number of common shares alongside the acquisition of phantom stock units as part of a compensation plan. This is a routine insider transaction and does not indicate a strong positive or negative sentiment about the company's performance or outlook.

Positives

• Acquisition of 2,863.0921 phantom stock units by a director, which represents a form of compensation and aligns the director's interests with the company's performance, albeit through a cash-settled instrument.

Negatives

• Disposition of 500 shares of common stock by a director, which, while a small amount, represents a reduction in direct equity ownership.

Future Outlook

NA

Industry Context

This document details a routine insider transaction for a director's compensation and personal stock management, which is common across all industries and does not provide specific insights into broader pharmaceutical industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: The disposition of 500 common shares by a director is a very minor transaction and is unlikely to have a material impact on shareholder sentiment or the company's stock price.
• Employees, Customers, Suppliers, Creditors: This filing has no direct impact on these stakeholder groups.

Key Dates

Keywords

Merck & Co., MRK, SEC Form 4, Insider Transaction, Stock Ownership, Director Compensation, Phantom Stock, Equity Compensation